Insights into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack after Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves)

Circulation: Cardiovascular Interventions

Volumn 9, Issue 9, 2016, Pages

  Kapadia, Samir ^a   Agarwal, Shikhar ^a   Miller, D Craig ^b   Webb, John G ^c   MacK, Michael ^d   Ellis, Stephen ^a   Herrmann, Howard C ^e   Pichard, Augusto D ^f   Tuzcu, E Murat ^a   Svensson, Lars G ^a   Smith, Craig R ^g   Rajeswaran, Jeevanantham ^a   Ehrlinger, John ^a   Kodali, Susheel ^g   Makkar, Raj ^h   Thourani, Vinod H ⁱ   Blackstone, Eugene H ^a   Leon, Martin B ^g  

^a LERNER RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f WASHINGTON HOSPITAL CENTER   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY   (United States)

Author keywords

Stroke; transapical; transcatheter aortic valve replacement; transfemoral; transient ischemic attack

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DEMENTIA; DUAL ANTIPLATELET THERAPY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTDILATATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL; TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; VASODILATATION; VISUAL ANALOG SCALE; AORTIC REGURGITATION; AORTIC VALVE STENOSIS; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEMORAL ARTERY; HEART CATHETERIZATION; KAPLAN MEIER METHOD; MORTALITY; PROCEDURES; PUNCTURE; REGISTER; RISK ASSESSMENT; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FEMORAL ARTERY; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; PUNCTURES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84988736229     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.002981     Document Type: Article

References (30)

1. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-2326. doi: 10.1016/j. jacc.2012.02.022.
2. Khatri PJ, Webb JG, Rodés-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158:35-46. doi: 10.7326/0003-4819-158-1-201301010-00007.
3. Athappan G, Gajulapalli RD, Sengodan P, Bhardwaj A, Ellis SG, Svensson L, Tuzcu EM, Kapadia SR. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol. 2014;63:2101-2110. doi: 10.1016/j.jacc.2014.02.540.
4. Browndyke JN, Mathew JP. Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired Circ Cardiovasc Interv. 2013;6:599-601. doi: 10.1161/CIRCINTERVENTIONS.113.001017.
5. Rodés-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, Costa MA, Mega JL, O'Donoghue ML, Ohman EM, Becker RC. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol. 2013;62:2349-2359. doi: 10.1016/j.jacc.2013.03.029.
6. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont E, Rodés-Cabau J. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041-3053. doi: 10.1161/CIRCULATIONAHA.112.110981.
7. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb JG, Leon MB, Smith CR; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-843.e13. doi: 10.1016/j. jtcvs.2012.01.055.
8. Fanning JP, Walters DL, Platts DG, Eeles E, Bellapart J, Fraser JF. Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture Circulation. 2014;129:504-515. doi: 10.1161/CIRCULATIONAHA.113.004103.
9. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695. doi: 10.1056/NEJMoa1200384.
10. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators. Transcatheter aorticvalve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704. doi: 10.1056/NEJMoa1202277.
11. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. doi: 10.1056/NEJMoa1008232.
12. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/NEJMoa1103510.
13. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of timevarying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615-624.
14. Andersen PK, Borgan O, Gill RD. Statistical Models Based on Counting Processes. Chapter 4: Nonparametric Estimation. New York: Springer-Verlag; 1993;176-331.
15. Breiman L. Bagging predictors. Machine Learning. 1996;24:123-140.
16. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093-2109.
17. Ishwaran H, Kogalur UB. Random forests for survival, regression, and classification (RF-SRC), R package version 1.6.0, URL: http://cran.rproject. org/web/packages/randomForestSRC/index.html. 2015. Accessed August 24, 2016.
18. Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841-860.
19. Rubin DB. Multiple Imputation for Non-Response in Surveys. New York: Wiley; 1987.
20. Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK, Cleman M, Reinöhl J, Cuisset T, Blackman D, Bolotin G, Spitzer S, Kappert U, Gilard M, Modine T, Hildick-Smith D, Haude M, Margolis P, Brickman AM, Voros S, Baumbach A. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070-2078. doi: 10.1093/eurheartj/ehv191.
21. Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lücke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G, Linke A. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016;316:592-601. doi: 10.1001/jama.2016.10302.
22. Tay EL, Gurvitch R, Wijesinghe N, Nietlispach F, Nielispach F, Wood D, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4:1290-1297. doi: 10.1016/j.jcin.2011.08.012.
23. Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015;131:1989-2000. doi: 10.1161/CIRCULATIONAHA.114.012525.
24. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28. doi: 10.1016/j. jacc.2010.07.036.
25. Dewey TM, Bowers B, Thourani VH, Babaliaros V, Smith CR, Leon MB, Svensson LG, Tuzcu EM, Miller DC, Teirstein PS, Tyner J, Brown DL, Fontana GP, Makkar RR, Williams MR, George I, Kirtane AJ, Bavaria JE, Mack MJ. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg. 2013;96:2083-2089. doi: 10.1016/j. athoracsur.2013.05.093.
26. Durand E, Blanchard D, Chassaing S, Gilard M, Laskar M, Borz B, Lafont A, Barbey C, Godin M, Tron C, Zegdi R, Chatel D, Le Page O, Litzler PY, Bessou JP, Danchin N, Cribier A, Eltchaninoff H. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2014;113:355-360. doi: 10.1016/j. amjcard.2013.09.033.
27. Poliacikova P, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation-comparison of regimes. J Invasive Cardiol. 2013;25:544-548.
28. Ussia GP, Scarabelli M, Mulè M, Barbanti M, Sarkar K, Cammalleri V, Immè S, Aruta P, Pistritto AM, Gulino S, Deste W, Capodanno D, Tamburino C. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2011;108:1772-1776. doi: 10.1016/j.amjcard.2011.07.049.
29. Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Stroke. 2014;45:1939-1946. doi: 10.1161/STROKEAHA.114.005296.
30. Messé SR, Acker MA, Kasner SE, Fanning M, Giovannetti T, Ratcliffe SJ, Bilello M, Szeto WY, Bavaria JE, Hargrove WC 3rd, Mohler ER 3rd, Floyd TF; Determining Neurologic Outcomes from Valve Operations (DeNOVO) Investigators. Stroke after aortic valve surgery: results from a prospective cohort. Circulation. 2014;129:2253-2261. doi: 10.1161/CIRCULATIONAHA.113.005084.